DURHAM, N.C., March 1, 2023 — InsightFinder, the leading predictive observability platform provider, rounded out a successful 2022 with a $10M Series A fundraising round and numerous product innovations for 2022. The fundraising round was led by Silicon Valley venture capital, and also included support from Yu Galaxy, Acadia Woods Partners, Eight Roads Ventures, Eastlink Capital, Fellows Fund, IDEA Fund Partners, and Triangle Tweener Fund.

InsightFinder obtained SOC2 compliant certification, taking a large step towards entertaining large brands at scale on the platform. In addition, InsightFinder has recently been listed on Datadog’s marketplace and as an Amazon certified partner. Both partnerships represent the highest standards of SaaS customer solutions, illustrating the critical value-add of InsightFinder’s incident prediction capabilities. The company has achieved over 200% subscription renewal from all of its customers for its award-winning incident prediction solution.

InsightFinder focused on several areas of innovation in 2022 including federated learning, cloud cost efficiency for Azure, AWS, GCP, predictive capacity planning and more. These advancements will enable customers to optimize their cloud application performance while reducing costs in ways previously unavailable or difficult to determine. .

InsightFinder is committed to delivering superior customer experience through its innovative products. With the newly raised funds and its upcoming product releases, InsightFinder is well positioned to continue its growth trajectory in 2023.

About InsightFinder:

DevSecOps, IT operations, and site reliability engineering (SRE) teams rely on InsightFinder to predict and prevent outages in complex distributed architectures. Powered by unique patented capabilities for incident prediction, unsupervised active learning and auto-remediation, the InsightFinder platform continuously learns from machine data to identify and fix problems before they impact web or application performance. Customers including Credit Suisse, Dell and Visa gain value quickly starting with an InsightFinders free trial and the company’s pre-built integrations with Datadog, New Relic, PagerDuty and other popular DevSecOps partners. Learn more at insightfinder.com 

InsightFinder.com | @InsightFinders | [email protected]

SOURCE InsightFinder

FREDERICK, Md., March 1, 2023 — Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology & Therapeutic Development Award (TTDA) of $4 million from the U.S. Department of Defense (DOD) awarded through the Peer Reviewed Medical Research Program (PRMRP) of the Congressionally Directed Medical Research Programs (CDMRP). The contract will fund its OsteoAdapt regenerative therapeutic product for spine and trauma repair to first in human clinical studies.

Theradaptive’s OsteoAdapt product was granted three breakthrough medical device designations by the U.S. Food and Drug Administration (FDA) in 2021 and 2022 for various spinal indications. OsteoAdapt is created by combining AMP2 protein, a novel bone regenerative biologic, with ReBOSSIS, a 510K-approved implant material. OsteoAdapt has the capability to precisely direct bone regrowth where it is needed in the body.

The funds from the DOD contract will enable Theradaptive to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices-compliant manufacturing of the OsteoAdapt product in preparation for clinical studies. After a request for an Investigational Device Exemption (IDE) is submitted to the FDA for approval, Theradaptive will initiate human clinical trials.

Theradaptive’s OsteoAdapt, powered by their proprietary AMP2 biologic, has beaten the standard of care in all preclinical studies to date. The DOD funding will enable the development of OsteoAdapt and the promise of life-changing surgery for Service Members and civilians with degenerative or traumatic spinal, extremity, craniomaxillofacial, and dental injuries.  37% of adults over the age of 30 and over 80% of adults over the age of 50 have at least one degenerated vertebral disc.

CEO and founder of Theradaptive, Dr. Luis Alvarez, Ph.D., believes the funding is a major step towards clinical trials: “This award affirms Theradaptive’s rapid and successful execution of earlier stage programs funded by Department of Defense, and provides funding crucial to advance a new kind of therapeutic that upon FDA approval will address massive unmet needs among Service Members, Veterans, and in the general population.”

“We understand the challenges that many service members face, particularly when traumatic extremity injuries progress to limb amputation or when years of physical activity lead to spinal degeneration, disc injury, and pain. The support provided by this contract will accelerate the completion of product development milestones that will allow Theradaptive to reach clinical trials faster and get us one step closer to providing this game-changing therapy to patients who need it most.”

Dr. Leon J. Nesti, a surgeon at the Walter Reed National Military Medical Center offers additional perspective: “Starting from early inspiration from Luis’s military career, Theradaptive has made significant progress in developing a regenerative technology that has now been demonstrated for orthopedic repair. Their technology offers a transformative approach to address medical challenges through regenerative mechanisms that stimulate stem cells, including the potential to restore patients’ quality of life by accelerating the process of bone regeneration. This technology is one of the few that addresses the stem cell niche directly by delivering growth factors to those stem cells. This work will have a large scientific impact and will benefit Service Members and Veterans.”

About Theradaptive

Founded in 2016 and headquartered in Maryland, U.S., Theradaptive is a venture-backed biopharmaceutical company with the goal of leveraging their therapeutic delivery platform that can deliver biologics where they are needed in the body with high precision and persistence to address unmet medical needs. Theradaptive is led by CEO Luis Alvarez, Ph.D., and its innovative platform has started to enable new therapeutics in spine, orthopedic and soft tissue repair as well as targeted immuno-oncology.

This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Medical Research Programs under Award No. (W81XWH-22-1-0875) for an amount of $3,979,465.00. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.

Contact:
Serena Lertora
[email protected]

SOURCE Theradaptive

New funding will enable Shef to help thousands more local cooks turn their
culinary talents into a small business

SAN FRANCISCO, March 1, 2023 — Shef, the nation’s leading chef-to-consumer marketplace, today announced plans to expand nationwide after closing a $73.5 million Series B funding round last year, bringing the company’s total funding to date to more than $100 million. The largest investment ever in a chef-to-consumer marketplace, the funding will help Shef connect talented local cooks anywhere in the United States with customers looking for healthy, high-quality food options prepared by members of their community.

Shef’s previously closed Series B round was led by CRV, with participation from Andreessen Horowitz and Amex Ventures. The round included $7M in venture debt. Other investors include celebrity chefs Andrew Zimmern (Bizarre Foods), Carla Hall (The Chew, Top Chef), Kristen Kish (Top Chef, Iron Chef) and Nyesha Arrington (Next Level Chef); athletes Russell Westbrook, Odell Beckham Jr. and Candace Parker; comedians Jimmy O. Yang and Lilly Singh; entrepreneur and best-selling author Tony Robbins; Visa CFO Vasant Prabhu; AngelList founder Naval Ravikant; Poshmark founder Manish Chandra; and former Airbnb executives Belinda Johnson and Joe Zadeh. They join a long list of existing investors including Katy Perry, Orlando Bloom, Aarón Sánchez, Andre Iguodala, and Alexis Ohanian.

Shef launched in the Bay Area in 2019 and currently operates in 11 states plus Washington, D.C., reaching 70 million people. Since its launch four years ago, thousands of local, food safety certified “shefs” – 85% of whom are women and 80% people of color – have joined the marketplace. Many are immigrants or refugees, representing nearly 100 countries around the world. Cooks on Shef have earned tens of millions of dollars of net income to support themselves and their families.

“Finding Shef has changed my life here,” said Shef Adriana, a Nicaraguan refugee who was forced to flee her beloved home country and successful Managua restaurant four years ago. “My dream is to open a restaurant again someday. Until then, Shef enables me to share my cherished family recipes with customers and earn much-needed income. It makes me so happy to give my customers a taste of where I come from, hopefully reminding them of their own mother’s or grandmother’s cooking too.”

The new funding will enable Shef to help thousands more local cooks turn their culinary talents into a small business for the first time, while meeting the needs of busy consumers looking for healthy, high-quality meal options. As of 2022, all 50 states now allow for the sale of certain types of homemade food, with many states clarifying laws to embrace and regulate the practice. Starting today, talented cooks anywhere across the country can apply to sell their homemade specialties on Shef. Shef will also be investing in key product developments, including new preference and customization features that will deliver a uniquely personalized experience.

“With our plans to bring Shef nationwide this year, we’re focused on enabling anyone, anywhere to become a food entrepreneur – something that would have been a true economic lifeline for both Alvin’s and my family when they immigrated to the U.S.,” said Shef co-founder and CEO Joey Grassia. “Demand for Shef has grown dramatically over the past four years – both from those interested in cooking on the platform to earn much-needed income, as well as consumers looking for more affordable, healthy ways to feed their families. We’re thrilled to be able to meet this demand and fill a significant gap in the market between home cooking and takeout.”

“Shef is not only incubating the next generation of American food entrepreneurs and future restaurant owners, they’re unlocking an entirely new category of how we feed our families,” said Saar Gur, general partner at CRV. “Neighbors feeding neighbors is already a widely accepted tradition around the world. Now talented local cooks can simultaneously pursue their passion while also providing their families with another meaningful source of income by providing homemade dishes to those nearby, something that’s even more relevant given the tough economy. We’re proud to support a company that puts the interests of shefs front and center while meeting a huge consumer demand for more healthy, high-quality food options in their community.”

“At American Express, we’re all about shopping small and supporting the next generation of small business owners,” said Kevin Tsang, Managing Director for Consumer Services Investments at Amex Ventures. “Shef has turned starting a small food business – something previously cost-prohibitive for most – into a reality for thousands of people across the country. In supporting Shef, we’re honored to invest in a majority female and people of color marketplace that’s dramatically lowering the price of entry into the food industry.”

Beyond supporting the fast-growing community of shefs across the country, Shef is also committed to giving back – both to non-profits and causes in places where Shef operates, as well as around the world. Shef and its customers have donated more than 10,000 meals to those in need. Shef also established an initiative to help Afghan refugees in the wake of the 2021 crisis, expediting the applications of any Afghan refugee interested in cooking on Shef and setting aside $3,500 per person to help pay for training, supplies, and marketing support.

About Shef

Shef is a chef-to-consumer marketplace that enables talented local cooks to connect directly with customers in their community and earn a meaningful income selling authentic, homemade dishes. Shef was founded by Joey Grassia and Alvin Salehi, both sons of immigrants whose parents struggled to make ends meet after arriving in the U.S. The “she” in Shef is in honor of their mothers who worked incredibly hard to support and nourish their families and communities. Shef is their way of bringing a community-based food system to life, where anyone can gain access to a meaningful income and take care of their neighbors, one meal at a time. The service is currently available in several markets across the United States, including San Francisco, New York, New Jersey, Seattle, Chicago, Houston, Austin, Boston, Los Angeles, Washington, D.C., Maryland, Virginia, and Atlanta, with plans to expand nationwide this year. To order food from a local cook in your area, or for more information on how to become a shef, visit www.shef.com.

Contact:
Amy Dudley, Head of Communications, Shef
[email protected]
203-470-5881

SOURCE Shef

• The round was led by Diagram Ventures with participation from Fenbushi Capital, Sfermion, Big Brain Holdings, Builder Capital and Sparkle Ventures (strategic venture arm supported by Animoca Brands and The Sandbox)
• Helika’s $4 million seed funding round will enable the company to expand its operations and develop its platform to better serve the Web3 community

TORONTO, March 1, 2023 – Helika, a Web3 gaming and NFT analytics platform, has announced the successful close of its $4 million seed funding round to scale product and marketing analytics for Web3. The funding round was led by Diagram Ventures, with participation from Sfermion, Sparkle Ventures, Big Brain Holdings, Fenbushi, and Builder Capital.

“We’re confident with our investment in Helika as they’ve shown impressive customer traction within NFT communities and with large game studios in a short amount of time,” said Ken Nguyen, Head of Crypto at Diagram Ventures. “We see Helika at the forefront of a rapidly evolving industry, and believe its innovative technology and forward-thinking approach position the company for significant growth in the years to come.”

Most companies in Web3 struggle to make data-driven decisions to drive growth. Helika’s no-code platform with integrated in-game, on-chain and social media analytics allows companies to understand their user’s behavior and interactions to increase engagement, retention, user acquisition, and make better strategic decisions. The platform offers a suite of powerful products allowing Helika clients such as Yuga Labs and Treasure to gather sales and royalty data, analyze user wallet activity, onboard new users, and determine optimal mint pricing for future NFT drops.

“We are thrilled to have the support of such a strong group of investors as we continue to build out our platform and expand our data sources,” said Anton Umnov, Founder and CEO of Helika. “This funding round will enable us to grow our team, improve our product, connect more sources of data from other blockchains, and continue to gather insights to share with the Web3 community.”

The lack of visibility on reach, retention, and revenue of NFT collections has been a major challenge for many web3 gaming studios and popular NFT projects.  Helika’s platform provides these insights so that top web3 companies can make informed, strategic decisions.

Helika’s $4 million seed funding round will enable the company to expand its operations and develop its platform to better serve the Web3 community.

About Helika

Helika is a web3 technology platform that delivers real-time analytics and onboards new users to gaming studios and popular NFT collections. With a focus on integrated analytics from Web2, in-game, on-chain and social media data, Helika helps top Web3 brands such as Yuga labs and Treasure to understand their communities, increase user acquisition and engagement, and drive overall growth with a data-driven approach.

Helika is backed by top VC firms including Diagram Ventures, Sfermion, Sparkle Ventures, Big Brain Holdings, Fenbushi and Builder Capital.

For more information, visit helika.io

SOURCE Helika

BOSTON, March 1, 2023 — Chloris Geospatial, a technology company that measures natural capital from space, closes seed extension round of funding led by AXA IM Alts and Orbia Ventures, with participation from existing investors At One Ventures and Counteract.

Companies are challenged with adopting nature-based solutions with increasing speed, scale, and integrity to meet climate and biodiversity goals. Chloris developed technology that uses satellite data to reliably assess forest carbon dynamics, including forest growth and degradation.

Marco Albani, CEO of Chloris Geospatial, commented, “We are excited to welcome AXA IM Alts and Orbia as new investors. The market needs robust and reliable natural capital insights to deploy high-integrity nature-based solutions. We will use the new funding to advance sensor-fusion technology and equip customers with globally consistent estimates for 2000-2022. This aligns with corporate sustainability reporting frameworks and allows us to assess the impact of forest projects in the voluntary carbon markets. The funding will also extend spatial coverage and grow customer support services.”

Jonathan Dean, Head of Impact Investing at AXA IM Alts, commented, “AXA IM Alts is committed to investing in companies and projects to preserve our planet’s natural ecosystems and address climate risk. Chloris’s innovative solutions will enhance the credibility of natural capital projects and associated ecosystem services claims and provide the necessary assurance to support continued investments in natural capital. This aligns with our ambition to create scalable solutions that contribute to global protection, restoration, and sustainable management of natural capital globally.”

Shai Albaranes, VP Innovation, and Ventures at Orbia commented, “We are delighted to be part of this round of funding in Chloris Geospatial. Climatech is a key focus area for Orbia Ventures, with this investment forming part of a wider strategy to implement our commitment to advancing life around the world by developing and investing in products and services that mitigate the impact of climate change and move us closer to our goal of being carbon neutral while helping decarbonize the planet.”

About Chloris Geospatial

Chloris Geospatial is a provider of science-based forest carbon insights built with Earth observation data and machine learning. The Chloris Platform enables high-integrity nature-based solutions to climate change. For more information, visit www.chloris.earth.

SOURCE Chloris Geospatial

TEL AVIV, Israel, March 1, 2023 — Hexa, a 3D asset visualization and management platform, announced it has raised a $20.5 Million Series A round from Point72 Ventures, Samurai Incubate, Sarona Partners, and HTC. Hexa’s proprietary tech stack digitizes products like furniture and fashion using existing 2D images and AI, creating a new 3D model, a digital twin of the physical object. This digital twin can then be deployed on websites, social media and in AR applications. The models are interactive, too. Consumers control the model with their cursor, allowing them to inspect the asset from any angle. Hexa provides storage, management, distribution, and analysis of the models its customers create.

Hexa believes the Internet will increasingly become 3D. These 3D spaces in the Metaverse need to be populated with dimensional objects, furnishings, displays, merchandise. Users can do more than simply look at things, they can navigate around them. Product pages will increasingly use 3D representations, replacing traditional 2D pictures and thumbnails. Hexa’s 3D tools guide brands and retailers as they create, manage, distribute, and analyze 3D projects.

“We are convinced 3D content will be at the heart of all online and offline retail,” says Hexa CEO and co-founder Yehiel Atias. “You have to make it easy to use, inexpensive, and fast to return on your investment.” Old methods of creating assets through photogrammetry or lidar scanning are less accurate and more expensive.

Amazon, Macy’s, Logitech, Unity and Crate & Barrel are among the dozens of companies that now use the Hexa 3D platform for making, managing and deploying their 3D assets. The models can be moved onto any web page, social media site, or game engine with a snippet of code. Hexa’s 3D Viewer facilitates parallel processing, loading at the maximum frames per second without sacrificing computational power. 3D models load as quickly as 2D images and are immediately interactive.

“Taking a product library, converting it to 3D, inspecting it and deploying it is a tremendous undertaking,” said co-founder and CTO Jonathan Clark. “But we’ve eliminated the pain points with a fast, scalable solution to a very specific problem everyone selling anything in the Metaverse is going to encounter.”

Having raised $1.2 million in pre-seed funding and $5.5 million in seed funding rounds, Hexa’s total funding to date stands at $27.2 million. With a team of 100 global employees working in engineering and business development, the company aims to utilize the new funding to support further expansion. 

About Hexa
Founded in 2018, Hexa is an industry leader focused on its mission to build the world’s most powerful 3D tech stack, supporting the many use cases of synthetic data. Hexa’s technology enables businesses to create, manage, distribute, and analyze high-fidelity 3D models, 360-degree viewing, and AR experiences at scale. For more information or to get in touch with Hexa, visit https://www.hexa3d.io/.

Media Contacts:
Shira Zwebner/Leigh Brandt
Lightspeed PR & Marketing for Hexa 
[email protected]
[email protected]

SOURCE Hexa

PALM BEACH, Fla., March 1, 2023 — Newly rebranded Viper Equity Partners, now Viper Partners, has launched a new division offering equipment, expansion and acquisition loans to doctors and medical business owners nationwide. As the MSO and DSO markets continue to enjoy massive growth, Viper recognizes that many doctors are not ready to sell. A newly launched program offers loans up to $10M with fast approvals and very competitive rates. Leading this new division is industry veteran, Karen E. Vickers. “I am so excited about this opportunity and agree with Viper on the necessity for “Top Shelf” representation for doctors looking for financial help.” Viper, true to form, has strong relationships with leading lenders, including JP Morgan Chase, and a goal of matching clients with programs that make sense (offering preapprovals in 72 hours in most cases).

Viper gets the business and understands doctors’ needs. Viper Founder, David C. Branch, saw the hole in their business model. “We have helped thousands of doctors with transitions and sale deals but not everyone is ready for an exit due to their age or specific goals. We want to help them now with their growth plans and then be there for them when it is time to exit.”

Viper will represent all doctors and provide assistance whether they need simple equipment loans, full expansion financing, buildouts, acquisitions or loan refinancing. Viper has a strong reputation among lenders which enables them to secure loan packages with better rates than brokers or doctors can get on their own.

Also new is Viper’s national roll out of a premier real estate division focused on selling medical commercial buildings. Armed with a national contract with Coldwell Banker, Viper launched this division in January and already has 17 properties under contract. Again, Viper responded to the demand from their clients to help them sell their buildings. Partners at Viper have over 30 years experience in this market, which is a huge benefit to doctors across all specialties. “It is so important in real estate to have true representation and knowledge. Exceptional deals are very available and we have the name and reputation that doctors trust,” stated David C. Branch.

Viper understands the medical business from both sides of the table. Their strong suit is bringing growth-minded practice owners to private equity and financing partners, and now with the launch of the Loan and Real Estate divisions, they continue to dominate all things medical and bring superior support to medical professionals.

Viper Partners is a leading investment banking firm. For more information contact Karen E. Vickers at [email protected] or (561)-951-1822

SOURCE Viper Partners

• doctorly GmbH (“doctorly”), is an innovative provider of comprehensive practice management software based in Germany.
• WELL Ventures, the venture capital arm of WELL, is leading an investment round in doctorly alongside Horizons Ventures and a syndicate of leading venture capital firms.
• As part of the investment and strategic alliance agreements, the Ocean platform, created by WELL’s wholly owned subsidiary, CognisantMD, will be used as the exclusive booking and practice engagement platform for doctorly. This will be WELL’s first commercial launch into the European market.

VANCOUVER, BC, March 1, 2023 – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (Frankfurt: W7V.F) (“WELL” or the “Company“), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce it has made a strategic investment, through its wholly owned subsidiary, WELL Ventures, in doctorly GmbH (“doctorly“), a medical practice management software provider based in Germany. WELL Ventures is investing as part of a syndicate of investors including of some of the world’s most renowned venture capital firms such as Horizons Ventures, The Delta Force AG, Speedinvest, UNIQA Ventures, Calm Storm and Seedcamp.

doctorly was founded in 2018 to overhaul the highly regulated medical practice software industry. doctorly’s home market of Germany still heavily relies on software built in the 1980’s and lags behind global competitors. Antiquated software and a lack of innovation has led to material inefficiencies. According to the Kassenärztliche Bundesvereinigung’ (“KBV“), the regulator for state practicing doctors in Germany, medical practices spend an average of 61 working days per year on administrative tasks. doctorly has built a modernized operating system that has successfully reduced the time dedicated to administrative tasks within practices cut in half. doctorly is currently the only venture capital backed start up in Germany with regulatory approval to sell and distribute practice management software, giving the company a unique opportunity for growth.

“There are two key firsts with this important event. This is our first co-investment with our friends and partners at Horizons Ventures and our first investment and collaboration agreement in Europe” said Hamed Shahbazi, CEO and Founder of WELL. “WELL and doctorly operate on the same principle of tech-enabling health care practitioners to improve patient outcomes. A key part of this important investment is the opportunity to secure the exclusive rights to launch our very popular and growing Ocean platform for online patient bookings in Germany with a strong and upcoming practice management tool in a market many times the size of Canada.”

Proceeds from the investing round will be used to invest in accelerating its growth in Germany. This will involve developing new features and functionality to reduce administrative costs and free up more time for healthcare professionals to focus on delivering healthcare.

WELL and doctorly will also work together on future projects within the German healthcare market following this investment round. The first of which involves the Ocean platform that was created by WELL’s subsidiary CognisantMD. The Ocean platform will be used as the exclusive booking and practice engagement platform for doctorly.

“Since inception, we have worked very closely with doctors and healthcare professionals to build an operating system that works for them” said Samir El-Alami, CEO and Founder of doctorly. “Our relationships have enabled us to build a practice management system that is modern, easy to use, secure and connects with other modern technologies. This commitment to improving the lives of our practitioners has led to excellent customer feedback, early sales traction, and now this investment round with pre-eminent investors and a strategic partner with WELL. This investment round makes doctorly the first company with regulatory approval to sell its software in Germany to receive VC funding.”

WELL Ventures’ mandate is to invest in and advance the digitization and modernization of healthcare in Canada and around the globe through venture-style investments in early-stage digital health companies. WELL Ventures’ graduates include Circle Medical and Insig; while current portfolio companies include Phelix.ai, Bright, Twig Fertility, Focus Mental Wellness, and Pillway. 

WELL HEALTH TECHNOLOGIES CORP.

Per: “Hamed Shahbazi” 
Hamed Shahbazi
Chief Executive Officer, Chairman and Director

About WELL Health Technologies Corp.

WELL is a practitioner focused digital health company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL’s own omni-channel patient services offerings. As such, WELL owns and operates Canada’s largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on OTCQX under the symbol “WHTCF“. To learn more about the Company, please visit: www.well.company.

About doctorly

Doctorly is a European based digital health-tech startup with a company mission of ‘enabling people to live healthier lives’. With an initial focus on Europe’s largest market, Germany, doctorly has built a brand new, fully regulated practice management software to redefine how medical practices work. As an all-in-one solution, doctorly provides a fully centralised, cloud powered, GDPR compliant, medical practice operating system that dramatically reduces the time & effort doctors & medical assistants spend on day-to-day administrative tasks. Doctorly is the only VC backed startup to ever have the regulatory approval to sell this software in Germany, and with over 110,000 medical practices live in the market, have big ambitions to support a large percentage of the doctors & medical professionals in modernising how they work. To learn more about doctorly please visit: www.doctorly.de.

SOURCE WELL Health Technologies Corp.

Partnership with experienced software investor to support LOGEX’s mission to turn data into better healthcare in Europe

AMSTERDAM and LONDON, March 1, 2023 — LOGEX, a European healthcare analytics provider, today announced an investment from Thoma Bravo, a leading software investment firm. LOGEX’s existing shareholders, the company’s founders, and Summa Equity will remain invested with the business and will work closely with Thoma Bravo and the executive committee to support LOGEX’s European growth and further drive innovation in healthcare analytics.

LOGEX is a leading healthcare analytics provider which uses data to help healthcare providers and hospitals make better decisions and deliver optimum health outcomes for patients while reducing costs. Founded in 2008 and headquartered in Amsterdam, LOGEX is currently active in ten countries with the ambition to further expand across Europe. 

“Our mission is to turn data into better healthcare. There is an urgent need for stronger, more resilient, and more accessible health systems in Europe. We are already active in 10 European markets and we know we can play a meaningful role in evolving healthcare in Europe and making systems interoperable for improved international collaboration if we can expand further. Thoma Bravo, with their deep technical knowledge and their expertise in operational excellence, will be a fantastic partner to help us achieve that goal,” said Philipp Jan Flach, Chief Executive Officer at LOGEX.

Thoma Bravo is an active investor in Europe, having deployed $11 billion of equity across 11 transactions there in the last 12 years. To further support the firm’s expansion in Europe, Thoma Bravo opened an office in London in September 2022 to grow the firm’s presence and investment activity. This marks Thoma Bravo’s inaugural investment by its Europe-based team.

“With its best-in-class software solutions that optimise the delivery and quality of care, LOGEX has a real-world impact on patients. We are excited to partner with LOGEX and its talented team to drive continued innovation and advance its mission to improve European healthcare. We look forward to leveraging Thoma Bravo’s demonstrated software and operations capabilities to help the company deliver on its plans,” said David Tse, a Vice President at Thoma Bravo.

Jefferies LLC served as exclusive financial advisor to LOGEX and Allen & Overy served as legal counsel. Kirkland & Ellis LLP served as legal counsel to Thoma Bravo and Harris Williams & Co. Ltd served as Thoma Bravo’s exclusive financial advisor.

About LOGEX

LOGEX is leading the way in healthcare analytics in Europe. By turning data into actionable insights, LOGEX helps solve the complex healthcare challenge of managing costs whilst improving clinical outcomes. Headquartered in Amsterdam and with an international team of over 450 members, LOGEX helps over 700 of public and private healthcare providers make data-driven decisions that level up patient outcomes everywhere and make the best possible care more affordable for everyone. For more information about LOGEX, its solutions and its partnerships, visit www.logex.com.

About Thoma Bravo

Thoma Bravo is one of the largest software investors in the world, with more than $120 billion in assets under management as of September 30, 2022. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo’s deep sector expertise and strategic and operational capabilities, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20 years, the firm has acquired or invested in more than 420 companies representing over $235 billion in enterprise value.¹ The firm has offices in Chicago, London, Miami and San Francisco. For more information, visit Thoma Bravo’s website at thomabravo.com and Twitter @ThomaBravo.

¹ Includes control and non-control investments.

SOURCE Thoma Bravo